- Xylem press release ( NYSE: XYL ): Q3 Non-GAAP EPS of $0.79 beats by $0.13 .
- Revenue of $1.38B (+8.7% Y/Y) beats by $40M .
- Outlook: Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent, and approximately 4 percent on a reported basis. This represents a raise of the low end of the Company’s previous full-year organic revenue guidance of 8 to 10 percent, and 3 to 5 percent on a reported basis. Full-year 2022 adjusted EBITDA margin is now expected to be approximately 17.0 percent, raising the low end of the previous range of 16.5 to 17.0 percent. This results in adjusted earnings per share of $2.65 to $2.75 vs consensus of $2.60, an increase from the previous range of $2.50 to $2.70. The increased guidance reflects strong demand, gradual easing of supply chain constraints, and price realization, partially offset by inflation and foreign exchange headwinds.
For further details see:
Xylem Non-GAAP EPS of $0.79 beats by $0.13, revenue of $1.38B beats by $40M, raises FY guidance